These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35987891)

  • 1. The Differential Risk of Mortality Among Users of Overactive Bladder Anticholinergic Medications and β3 Agonists.
    Welk B
    Eur Urol Focus; 2023 Jan; 9(1):168-171. PubMed ID: 35987891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of Dementia After Treatment with an Anticholinergic, Beta-3 Agonist, or Combination of Both for an Overactive Bladder: A Korean National Cohort Study.
    Park JS; Choi SB; Jang WS; Kim J; Ham WS
    Eur Urol Focus; 2024 Mar; 10(2):306-314. PubMed ID: 38388215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of delirium and falls or fractures with the use of overactive bladder anticholinergic medications.
    Welk B; Etaby K; McArthur E; Chou Q
    Neurourol Urodyn; 2022 Jan; 41(1):348-356. PubMed ID: 34719044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxybutynin-associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment.
    Chancellor MB; Lucioni A; Staskin D
    Urology; 2024 Apr; 186():123-129. PubMed ID: 38296001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cognitive effect of anticholinergics for patients with overactive bladder.
    Welk B; Richardson K; Panicker JN
    Nat Rev Urol; 2021 Nov; 18(11):686-700. PubMed ID: 34429535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study.
    Welk B; McArthur E
    BJU Int; 2020 Jul; 126(1):183-190. PubMed ID: 32167223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inequities in Filled Overactive Bladder Medication Prescriptions in the US.
    Luchristt D; Bretschneider CE; Kenton K; Simon M; Brown O
    JAMA Netw Open; 2023 May; 6(5):e2315074. PubMed ID: 37223899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which anticholinergic drug for overactive bladder symptoms in adults.
    Madhuvrata P; Cody JD; Ellis G; Herbison GP; Hay-Smith EJ
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005429. PubMed ID: 22258963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of vibegron for the treatment of overactive bladder in the United States.
    Chen JV; Klein TM; Nesheim J; Mudd PN
    J Med Econ; 2022; 25(1):1092-1100. PubMed ID: 35993729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are anticholinergic medications used for overactive bladder associated with new onset depression? A population-based matched cohort study.
    Welk B; McArthur E
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1710-1714. PubMed ID: 33015899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient and Clinician Challenges with Anticholinergic Step Therapy in the Treatment of Overactive Bladder: A Narrative Review.
    Dmochowski RR; Newman DK; Rovner ES; Zillioux J; Malik RD; Ackerman AL
    Adv Ther; 2023 Nov; 40(11):4741-4757. PubMed ID: 37725308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticholinergic medication use for female overactive bladder in the ambulatory setting in the United States.
    Ju R; Garrett J; Wu JM
    Int Urogynecol J; 2014 Apr; 25(4):479-84. PubMed ID: 24158462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive changes in women starting anticholinergic medications for overactive bladder: a prospective study.
    Iyer S; Lozo S; Botros C; Wang C; Warren A; Sand P; Tomezsko J; Botros S; Gafni-Kane A; Sasso K; Goldberg RP
    Int Urogynecol J; 2020 Dec; 31(12):2653-2660. PubMed ID: 31813036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral medications on fMRI brain activation: A randomized, double blind, controlled pilot trial of older women with overactive bladder.
    High RA; Shi Z; Danford JM; Bird ET; Karmonik C; Khavari R
    Int Urogynecol J; 2023 May; 34(5):1035-1042. PubMed ID: 35925203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.
    Anderson RU; MacDiarmid S; Kell S; Barada JH; Serels S; Goldberg RP
    Int Urogynecol J Pelvic Floor Dysfunct; 2006 Sep; 17(5):502-11. PubMed ID: 16724169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study.
    Szabo SM; Gooch K; Schermer C; Walker D; Lozano-Ortega G; Rogula B; Deighton A; Vonesh E; Campbell N
    BMJ Open; 2019 May; 9(5):e026391. PubMed ID: 31061036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Twilight Zone: Oxybutynin Overuse Exacerbating Delirium.
    Marthi S; Pomerantz MA; Mernan AJ; Berlow YA
    J Geriatr Psychiatry Neurol; 2022 Nov; 35(6):840-845. PubMed ID: 35383492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study.
    Just KS; Schultze KA; Dormann H; Seufferlein T; Gräff I; Scholl C; Schwab M; Stingl JC
    Eur J Clin Pharmacol; 2023 Sep; 79(9):1185-1193. PubMed ID: 37382655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents.
    Lua LL; Pathak P; Dandolu V
    Neurourol Urodyn; 2017 Nov; 36(8):2123-2131. PubMed ID: 28467609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.